Rhabdomyolysis and acute kidney injury secondary to concomitant use of fluvastatin and rapamycin in a renal transplant recipient

Nephrology Dialysis Transplantation

Volumn 25, Issue 6, 2010, Pages 2036-

  Basic Jukic, Nikolina ^a   Kes, Petar ^a   Bubic Filipi, Ljubica ^a   Vranjican, Zoran ^a  

^a KBC Zagreb   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CREATINE KINASE; CREATININE; CYCLOSPORIN A; FLUINDOSTATIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; SIMVASTATIN; STEROID;

AGED; ANAMNESIS; CADAVER DONOR; CASE REPORT; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DIALYSIS; DRUG WITHDRAWAL; DYSLIPIDEMIA; ESCHERICHIA COLI; FEMALE; GRAFT RECIPIENT; HUMAN; KIDNEY ALLOGRAFT; KIDNEY INJURY; LETTER; PRIORITY JOURNAL; RHABDOMYOLYSIS; SEPSIS; UREA NITROGEN BLOOD LEVEL;

DRUG INTERACTIONS; FATTY ACIDS, MONOUNSATURATED; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNOSUPPRESSIVE AGENTS; INDOLES; KIDNEY FAILURE, ACUTE; KIDNEY TRANSPLANTATION; RHABDOMYOLYSIS; SIROLIMUS;

EID: 77952977236     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq157     Document Type: Letter

References (5)

1. Hurst FP, Neff RT, Jindal RM et al. Incidence, predictors and associated outcomes of rhabdomyolysis after kidney transplantation. Nephrol Dial Transplant 2009; 24: 3861-3866
2. Dopazo C, Bilbao I, Lazaro JL et al. Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin with rapamy-cin plus tacrolimus in liver transplant patients. Transplant Proc 2009; 41: 1021-1024
3. Kasiske B, Cosio FG, Beto J et al. Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Am J Transplant 2004; 4: 13-53
4. Jacob A, Zhou M, Wu R, Wang P. The role of hepatic cytochrome P-450 in sepsis. Int J Clin Exp Med 2009; 2: 203-211
5. Link E, Parish S, Armitage J et al. SLCO1B1 variants and statin-induced myopathy\a genomewide study. N Engl J Med 2008; 359: 789-799